U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ITOLIZUMAB
XQQ2RHV14N
Investigational
General
Names
10
Classification
3
Identifiers
8
Subunits
4
Related Substances
1
ITOLIZUMAB
XQQ2RHV14N
Investigational
General
Approval Year
Unknown
139,594
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ITOLIZUMAB
Official Name
English
EQ001
Code
English
Immunoglobulin G1, anti-(human antigen CD6) (human-mouse monoclonal T1h heavy chain), disulfide with human-mouse monoclonal T1h light chain, dimer
Common Name
English
Immunoglobulin G1-kappa, anti-[Homo sapiens CD6 (Tp120, T12)], humanized monoclonal antibody; gamma1 heavy chain (1-449) [humanized VH (Homo sapiens IGHV3-21*08 (83.70%) -(IGHD)-IGHJ5*01) [8.8.12] (1-119)-Homo sapiens IGHG1*01 (120-449)], (222-214')-disu
Common Name
English
EQ-001
Code
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of acute graft versus host disease
FDA ORPHAN DRUG
646718
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated
ORPHAN DRUG
Designated
Prevention of acute graft versus host disease
FDA ORPHAN DRUG
676618
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
9321
PRIMARY
WIKIPEDIA
ITOLIZUMAB
PRIMARY
CAS
1116433-11-4
PRIMARY
FDA UNII
XQQ2RHV14N
PRIMARY
NCI_THESAURUS
C95787
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
XQQ2RHV14N
ITOLIZUMAB